Indivior Pharmaceuticals, Inc. (INDV) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.
Key numbers for Indivior Pharmaceuticals, Inc. (INDV): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.
AllSight quality score: 63/100 — a percentile rank of Indivior Pharmaceuticals, Inc.’s fundamentals against Manufacturing peers, weakest on financial health. A quality ranking, not a price prediction.
| Market cap | $4.2B |
| P / E | 11.9× |
| P / S | 3.2× |
| EV / EBITDA | 10.4× |
| Gross margin | 82.0% |
| Operating margin | 31.5% |
| Net margin | 26.7% |
| Return on equity | -170.7% |
| ROIC | 665.6% |
| Revenue growth | 13.5% |
| Debt / equity | -2.3× |
| Dividend yield | 0.0% |
Independent of the events above — derived from Indivior Pharmaceuticals, Inc.’s own financial statements and shown as context, never as advice.
About AllSight · Editorial standards & method · Contact